CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-06-10 | Henderson Molly CFO | Grant or award · Stock Option | +50,000 | 50,000 | ||
| 2016-06-01 | Henderson Molly CFO | Grant or award · Stock Option | +150,000 | 150,000 | ||
| 2016-03-11 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option (right to buy) | +100,000 | 100,000 | ||
| 2015-12-28 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option (right to buy) | +21,116 | 21,116 | ||
| 2015-06-08 | Henderson Molly Chief Financial Officer | Grant or award · Stock Option | +200,000 | 200,000 |
Page 1 of 1 · 5 trades